173 related articles for article (PubMed ID: 1082456)
41. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
Prager MD; Granatek CH; Ludden CM
Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
[TBL] [Abstract][Full Text] [Related]
42. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
Azuma H; Phillips JD; Green WR
J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
[TBL] [Abstract][Full Text] [Related]
43. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
44. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
45. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
46. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
Koren HS; Hodes RJ
Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
[TBL] [Abstract][Full Text] [Related]
47. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
48. Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens.
Engers HD; Thomas K; Cerottini JC; Brunner KT
J Immunol; 1975 Aug; 115(2):356-60. PubMed ID: 807632
[TBL] [Abstract][Full Text] [Related]
49. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
Ting CC; Rodgigues D; Bushar GS; Herberman RB
J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
[TBL] [Abstract][Full Text] [Related]
50. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
Suzuki H; Quintáns J
J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
[TBL] [Abstract][Full Text] [Related]
51. Generation of virus-specific cytotoxic T cells in vitro. I. Induction conditions of primary and secondary Sendai virus-specific cytotoxic T cells.
Koszinowski UH; Simon MM
Eur J Immunol; 1979 Sep; 9(9):715-22. PubMed ID: 92413
[TBL] [Abstract][Full Text] [Related]
52. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71.
Lee JC; Ihle JN
J Immunol; 1977 Mar; 118(3):928-34. PubMed ID: 191530
[TBL] [Abstract][Full Text] [Related]
53. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
Teh HS; Yu M
J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
[TBL] [Abstract][Full Text] [Related]
54. Abrogation of anti-Pichinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection or interleukin 2.
Walker CM; Paetkau V; Rawls WE; Rosenthal KL
J Immunol; 1985 Aug; 135(2):1401-7. PubMed ID: 2989365
[TBL] [Abstract][Full Text] [Related]
55. Generation of cytolytic t lymphocytes in vitro from alloimmune spleen cells.
Cerottini JC; Engers HD; Fitch FW; Brunner KT
Transplant Proc; 1976 Sep; 8(3):387-91. PubMed ID: 62429
[No Abstract] [Full Text] [Related]
56. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
57. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages.
Igarashi T; Teranishi T; Rodrigues D; Yamamura Y
Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022
[TBL] [Abstract][Full Text] [Related]
58. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
Srinivasa Rao V; Bonavida B
Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
[TBL] [Abstract][Full Text] [Related]
59. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
60. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
